2025-12-31 - Analysis Report
Okay, here's a comprehensive report on Sempra (SRE), incorporating the provided data and analysis.

**Report on Sempra (SRE)**

**Company Overview:**

Sempra is an energy infrastructure company that focuses on electric and natural gas infrastructure.

**1. Return Rate Comparison:**

*   **SRE Cumulative Return:** 15.89%
*   **VOO (S&P 500) Cumulative Return:** 102.21%
*   **Divergence:**
    *   Current Divergence: -87.9
    *   Relative Divergence: 4.4 (This suggests the current divergence is near the bottom of its historical range).

**Analysis:** Sempra has significantly underperformed the S&P 500 over the period for which cumulative returns are measured. The relative divergence suggests that the current underperformance is at the lower end of its historical fluctuation range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2015-2017  | 8.0%   | 70.6% | -20.0% | 0.0  | 34.9   |
| 2016-2018  | 11.0%  | 71.1% | -4.0%  | 0.1  | 35.3   |
| 2017-2019  | 35.0%  | 71.1% | 13.0%  | 0.3  | 49.4   |
| 2018-2020  | -4.0%  | 80.1% | -28.0% | 0.2  | 41.6   |
| 2019-2021  | -2.0%  | 80.1% | -49.0% | 0.4  | 43.2   |
| 2020-2022  | -15.0% | 81.1% | -14.0% | 0.4  | 50.4   |
| 2021-2023  | 22.0%  | 81.1% | 20.0%  | 0.5  | 48.8   |
| 2022-2024  | 11.0%  | 81.1% | -10.0% | 0.6  | 57.2   |
| 2023-2025  | -13.0% | 74.5% | -80.0% | -0.1 | 58.1   |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate (CAGR) varies significantly across different periods, with both positive and negative growth.
*   **MDD:**  The Maximum Drawdown (MDD) is consistently high, indicating substantial risk and volatility.
*   **Alpha:** The Alpha is mostly negative, suggesting underperformance compared to the benchmark, after adjusting for risk. This is particularly notable in the most recent 2023-2025 period with a very negative alpha.
*   **Beta:** The Beta is generally low (close to 0), indicating that Sempra's price is not strongly correlated to the market. In recent years, Beta has increased slightly, suggesting increasing market sensitivity, but the 2023-2025 period shows a negative Beta, implying an inverse correlation.
*   **Cap:** Sempra's Market Capitalization (Cap) has fluctuated, showing growth overall but with some periods of decline.

**2. Recent Stock Price Fluctuations:**

*   **Current Close:** 89.09
*   **Previous Close:** 88.91
*   **Change:** 0.2
*   **5-day SMA:** 88.83
*   **20-day SMA:** 88.87
*   **60-day SMA:** 91.18

**Analysis:** The current price is slightly above the 5-day and 20-day SMAs, suggesting a possible short-term upward trend. However, the 60-day SMA is significantly higher, indicating that the longer-term trend might be downwards.

**3. Indicators Analysis:**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 57.06 (Neutral)
*   **PPO:** 0.17 (Neutral)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (24 shares - Very Safe - MRI:0.90)
*   **Recent (20 days) relative divergence change:** -2.1 (Negative - Short-term decline)
*   **Expected Return (%):** -795.2 (Negative Excess Return)

**Analysis:**

*   The high MRI suggests that the overall market conditions are favorable for investment.
*   The RSI of 57.06 indicates a neutral condition, neither overbought nor oversold.
*   The PPO of 0.17 is also fairly neutral.
*   The Hybrid Signal suggests a strong buy recommendation according to the indicator.
*   However, the recent negative change in relative divergence and the very low expected return are concerning. These indicators suggest a strong negative view on Sempra specifically.

**4. Recent News & Significant Events:**

*   **[2025-12-05] Sempra (SRE) Down 2.9% Since Last Earnings Report: Can It Rebound?** - Suggests recent earnings disappointed investors.
*   **[2025-12-20] Sempra Energy $SRE Stock Holdings Lifted by Perpetual Ltd** - Indicates institutional investor confidence.
*   **[2025-12-19] SRE Stock Forecasts and Market Perspective** - Highlights ongoing market analysis.
*   **[2025-12-22] How To Earn $500 A Month From Sempra Stock** - Focuses on potential income generation.
*   **[2025-11-24] Sempra recognized among 'America's Best Employers for Company Culture' by Forbes** - Positive news about the company's work environment.
*   **[2025-10-09] Sempra Stock Is Good, But These Two Peers Are Better** - Suggests there might be better investment opportunities in the same sector.

**Analysis:** The news is mixed. While some articles point to potential income and institutional interest, others highlight underperformance, earnings concerns, and the existence of potentially better alternatives.

**4-2. Analyst Opinions:**

*   **Consensus:** Buy
*   **Mean Rating:** 1.82 (Buy)
*   **Number of Opinions:** 15
*   **Target Price:** $100.07 (Avg), $115.00 (High), $87.00 (Low)

**Analysis:** Analysts generally have a positive outlook on Sempra, with a consensus "Buy" rating and an average target price significantly above the current price. However, the wide range between the high and low target prices suggests some uncertainty in the analyst community. Recent Rating changes were not provided.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-11-05 | 0.12 | 2.76 B$   |
| 2025-08-07 | 0.71 | 2.70 B$   |
| 2025-05-08 | 1.39 | 3.68 B$   |
| 2024-11-06 | 1.01 | 2.57 B$   |
| 2025-11-05 | 1.01 | 2.57 B$   |

**Analysis:** The recent EPS data shows a decline, with the most recent EPS being significantly lower than previous quarters. Revenue has been variable. This data supports the negative sentiment from the news headlines regarding recent earnings. Note: There is a duplicate entry of 2025-11-05.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-09-30   | $3.15B   | 42.94%        |
| 2025-06-30   | $3.00B   | 46.73%        |
| 2025-03-31   | $3.80B   | 47.21%        |
| 2024-12-31   | $3.76B   | 49.23%        |
| 2024-09-30   | $2.78B   | 44.49%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-09-30   | $31.17B  | 0.30%    |
| 2025-06-30   | $31.72B  | 1.49%    |
| 2025-03-31   | $31.66B  | 2.90%    |
| 2024-12-31   | $31.24B  | 2.16%    |
| 2024-09-30   | $29.72B  | 2.18%    |

**Analysis:** Revenue has fluctuated. Profit margins have been consistently high, but show a slight downward trend in the recent quarter. Equity has generally increased, but Return on Equity (ROE) has declined significantly in the most recent quarter, mirroring the decline in EPS.

**7. Comprehensive Analysis:**

Sempra (SRE) presents a mixed picture.

*   **Negative Factors:**
    *   Significant underperformance compared to the S&P 500.
    *   High Maximum Drawdown, indicating high volatility.
    *   Mostly negative Alpha, meaning that the investment's underperformance vs the benchmark, after adjusting for risk.
    *   Declining EPS and ROE in recent quarters.
    *   Negative change in relative divergence, suggesting short-term decline.
    *   Extremely negative expected return.

*   **Positive Factors:**
    *   High Market Risk Indicator (MRI), suggesting favorable overall market conditions.
    *   Analyst consensus is "Buy" with a target price above the current price.
    *   Institutional investor interest indicated by increased holdings.
    *   Recognition for Company Culture.
    *   High profit margins.

**Conclusion:**

While analysts have a generally positive outlook and the company is recognized for its culture, the data suggests that Sempra is facing some challenges. The recent earnings decline, underperformance compared to the S&P 500, very negative expected return and the decline in ROE are concerning. Investors should carefully consider these factors before making an investment decision. The analyst "Buy" recommendation should be viewed cautiously in light of the data presented. It's advisable to conduct further research and consider individual risk tolerance before investing in SRE.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.